Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

25 results
Display

Single Nodular Opacity of Granulomatous Pneumocystis Jirovecii Pneumonia in an Asymptomatic Lymphoma Patient

Kim HS, Shin KE, Lee JH

The radiologic findings of a single nodule from Pneumocystis jirovecii pneumonia (PJP) have been rarely reported. We described a case of granulomatous PJP manifesting as a solitary pulmonary nodule with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Liver Abscess in Advanced Hepatocellular Carcinoma after Sorafenib Treatment

Shin SK, Jung YK, Yoon HH, Kwon OS, Kim YS, Choi DJ, Kim JH

Hepatocellular carcinoma (HCC) is a critical global health issue and the third most common cause of cancer-related deaths worldwide. The majority of patients who present HCC are already at an...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Molecular Targeted Therapy in Modern Oncology: Imaging Assessment of Treatment Response and Toxicities

Krajewski , Braschi-Amirfarzan M, DiPiro PJ, Jagannathan JP, Shinagare

Oncology is a rapidly evolving field with a shift toward personalized cancer treatment. The use of therapies targeted to the molecular features of individual tumors and the tumor microenvironment has...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Disseminated Intra-abdominal Gastrointestinal Stromal Tumor Managed with Low Dose Imatinib

Jang BH, Kim BW, Lim KJ, Kim BG, Park SM, Kim JS, Ji JS, Choi H

Gastrointestinal stromal tumor (GIST) is the most common mesenchymal tumor of the gastrointestinal tract. Imatinib mesylate is recommended as adjuvant therapy for GIST after surgical resection. However, drug-related adverse events...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Immune-Checkpoint Inhibitors in the Era of Precision Medicine: What Radiologists Should Know

Braschi-Amirfarzan M, Tirumani S, Hodi FS, Nishino M

Over the past five years immune-checkpoint inhibitors have dramatically changed the therapeutic landscape of advanced solid and hematologic malignancies. The currently approved immune-checkpoint inhibitors include antibodies to cytotoxic T-lymphocyte antigen-4,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
GnRH Agonist Therapy to Protect Ovarian Function in Young Korean Breast Cancer Patients

Park HJ, Koo YA, Im YH, Yoon BK, Choi D

The increased survival of patients with breast cancer has given rise to other problems associated with the complications of chemotherapy. One major complication is premature ovarian failure, an especially harmful...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Pneumatosis Intestinalis Associated with Sunitinib Treatment for Renal Cell Carcinoma

Choi YA, Sim EH, Lee KE, Ko SY, Seo MJ, Yang YJ, Park JC, Park SY

Sunitinib as a multitarget tyrosine kinase inhibitor is one of the anti-tumor agents, approved by the United States Food and Drug Administration to use treat gastrointestinal stromal tumor and metastatic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Pralatrexate in Combination with Bortezomib for Relapsed or Refractory Peripheral T Cell Lymphoma in 5 Elderly Patients

Lee SS, Jung SH, Ahn JS, Kim YK, Cho MS, Jung SY, Lee JJ, Kim HJ, Yang DH

Peripheral T cell lymphoma (PTCL) is a heterogeneous group of aggressive lymphomas with poor prognosis. Elderly (age ≥ 65years) patients generally have impaired bone marrow function, altered drug metabolism, comorbidities,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Relationship between Quality of Life and Nurse-led Bedside Symptom Evaluations in Patients with Chemotherapy-induced Peripheral Neuropathy

Yoo YS, Cho OH

  • KMID: 2069893
  • Asian Nurs Res.
  • 2014 Mar;8(1):36-41.
PURPOSE: This cross-sectional study aimed at determining the relationship between patient-reported quality of life (QOL) and nurse-led bedside evaluations of chemotherapy-induced peripheral neuropathy symptoms. METHODS: One hundred ninety-five patients treated at...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Behenoyl cytarabine-associated reversible encephalopathy in a patient with acute myelogenous leukemia

Cho SG, Moon H, Lee JH, Lee SY, Kim CC, Lee KS

We report a case of reversible encephalopathy syndrome in a 16-year-old girl with acute myelogenous leukemia (AML), who is undergoing during consolidation chemotherapy composed of BH-AC (N4-behenoyl-1-beta-D-arabinofuranosyl cytosine) and idarubicin....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Efficacy and safety of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma as first-line therapy

Oh MJ, Lee HJ, Lee SH

BACKGROUND/AIMS: Hepatic arterial infusion chemotherapy (HAIC) with 5-fluorouracil and cisplatin for intractable advanced hepatocellular carcinoma (HCC) may have survival benefits. We aimed to determine the efficacy and safety of HAIC...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Meta-analysis of Chemotherapy related Cognitive Impairment in Patients with Breast Cancer

Park JH, Bae SH

PURPOSE: The purpose of this study was to evaluate the cognitive effects of chemotherapy in patients with breast cancer. METHODS: Using several databases, prospective studies were collected up to August 2011....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Hydroxyurea Induced Perimalleolar Ulcers

Saravu K, Velappan P, Lakshmi N, Shastry BA, Thomas J

Hydroxyurea (HU) is an antineoplastic drug commonly used to treat chronic myeloproliferative disorders. Common dermatological side effects include hyperpigmentation, scaling, erythema, alopecia, desquamation of face and hands. Leg ulceration following...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
5-Fluorouracil-induced leukoencephalopathy in patients with breast cancer

Choi SM, Lee SH, Yang YS, Kim BC, Kim MK, Cho KH

The purpose of this study is to determine the characteristic clinical features, radiologic findings, and precipitating and prognostic factors in the patients with breast cancer and with 5-Fluorouracil (5-FU)-induced leukoencephalopathy....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Third-line docetaxel chemotherapy for recurrent and metastatic gastric cancer

Lee JH, Kim SH, Oh SY, Lee S, Lee H, Lee HJ, Kim HJ

BACKGROUND/AIMS: To determine the efficacy and toxicity of docetaxel as a third-line therapy for patients with relapsed gastric cancer who have undergone modified oxaliplatin-fluorouracil (m-FOLFOX)-4 and modified irinotecan-fluorouracil (m-FOLFIRI) regimens. METHODS:...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A study of hepatitis B virus reactivation associated with rituximab therapy in real-world clinical practice: a single-center experience

Oh MJ, Lee HJ

BACKGROUND/AIMS: The widespread use of cytotoxic chemotherapy and immunosuppressants has resulted in reactivation of hepatitis B virus (HBV) recently becoming an issue. Although rituximab (an anti-CD20 monoclonal antibody) has revolutionized...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A comparative study of sorafenib and metronomic chemotherapy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma with poor liver function

Yang H, Woo HY, Lee SK, Han JW, Jang B, Nam HC, Lee HL, Lee SW, Song DS, Song MJ, Oh JS, Chun HJ, Jang JW, Lozada A, Bae SH, Choi JY, Yoon SK

BACKGROUND/AIMS: Metronomic chemotherapy (MET) is frequently administered in comparatively low doses as a continuous chemotherapeutic agent. The aim of this study was to evaluate the feasibility and overall survival (OS)...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Concurrent Male Gynecomastia and Testicular Hydrocele after Imatinib Mesylate Treatment of a Gastrointestinal Stromal Tumor

Kim H, Chang HM, Ryu MH, Kim TW, Sohn HJ, Kim SE, Kang HJ, Park S, Lee JS, Kang YK

We report a gastrointestinal stromal tumor (GIST) patient with male gynecomastia and testicular hydrocele after treatment with imatinib mesylate. A 42 yr-old male patient presented for management of hepatic masses....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Practical Effect of Sorafenib Monotherapy on Advanced Hepatocellular Carcinoma and Portal Vein Tumor Thrombosis

Jeong SW, Jang JY, Shim KY, Lee SH, Kim SG, Cha SW, Kim YS, Cho YD, Kim HS, Kim BS, Kim KH, Kim JH

  • KMID: 1712330
  • Gut Liver.
  • 2013 Nov;7(6):696-703.
BACKGROUND/AIMS: We investigated the effects of sorafenib monotherapy on advanced hepatocellular carcinoma (HCC) and portal vein tumor thrombosis (PVTT) in a clinical setting. METHODS: In total, 143 consecutive patients with unresectable...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Pancreatic Endocrine Tumors: A Report on a Patient Treated with Sorafenib

Jeong HK, Roh SY, Hong SH, Won HS, Jeon EK, Shin OR, Lee SL, Ko YH

A 31-yr-old man with abdominal pain was diagnosed with a pancreatic endocrine tumor and multiple hepatic metastases. Despite optimal treatment with interferon alpha, a somatostatin analog, local therapy with high-intensity...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr